IRTCiRhythm Technologies, Inc.

Nasdaq irhythmtech.com


$ 102.96 $ -2.35 (-2.23 %)    

Friday, 21-Jun-2024 15:59:52 EDT
QQQ $ 479.17 $ 0.00 (0 %)
DIA $ 391.56 $ -0.73 (-0.19 %)
SPY $ 544.47 $ -0.73 (-0.13 %)
TLT $ 93.96 $ 0.00 (0 %)
GLD $ 214.79 $ -3.38 (-1.55 %)
$ 103.02
$ 103.06
$ 0.00 x 0
$ 0.00 x 0
$ 101.42 - $ 105.70
$ 70.24 - $ 124.12
981,692
na
3.2B
$ 1.31
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-22-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-04-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 11-04-2022 09-30-2022 10-Q
8 08-05-2022 06-30-2022 10-Q
9 05-06-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 11-05-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-10-2021 03-31-2021 10-Q
14 02-26-2021 12-31-2020 10-K
15 11-06-2020 09-30-2020 10-Q
16 08-07-2020 06-30-2020 10-Q
17 05-08-2020 03-31-2020 10-Q
18 03-02-2020 12-31-2019 10-K
19 12-23-2019 09-30-2019 10-Q
20 08-06-2019 06-30-2019 10-Q
21 05-10-2019 03-31-2019 10-Q
22 03-04-2019 12-31-2018 10-K
23 10-30-2018 09-30-2018 10-Q
24 08-03-2018 06-30-2018 10-Q
25 05-10-2018 03-31-2018 10-Q
26 03-01-2018 12-31-2017 10-K
27 11-14-2017 09-30-2017 10-Q
28 08-07-2017 06-30-2017 10-Q
29 05-12-2017 03-31-2017 10-Q
30 03-31-2017 12-31-2016 10-K
31 12-05-2016 09-30-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 chinas-bilibili-and-ollies-bargain-outlet-were-among-10-mid-cap-stocks-with-biggest-gains-in-the-last-week-june-16-june-22-2024-are-they-in-your-portfolio

Top performing mid-cap stocks last week: BILI (+23%), IBRX (+22%), SSL (+20%), OLLI (+15%), ITCI (+13%), AMKR (+12%), IRTC (+11...

 wolfe-research-upgrades-irhythm-technologies-to-outperform-announces-115-price-target

Wolfe Research analyst Mike Polark upgrades iRhythm Technologies (NASDAQ:IRTC) from Peer Perform to Outperform and announces...

 novavax-and-agios-pharmaceuticals-were-among-the-10-biggest-mid-cap-gainers-last-week-june-1-june-7-are-these-in-your-portfolio

Mid-cap stocks saw significant gains last week, with top performers like AGIO, VRNT, and NVAX, causing analysts to raise their ...

 canaccord-genuity-maintains-buy-on-irhythm-technologies-lowers-price-target-to-122

Canaccord Genuity analyst William Plovanic maintains iRhythm Technologies (NASDAQ:IRTC) with a Buy and lowers the price targ...

 needham-maintains-buy-on-irhythm-technologies-raises-price-target-to-138

Needham analyst David Saxon maintains iRhythm Technologies (NASDAQ:IRTC) with a Buy and raises the price target from $137 to...

 irhythm-technologies-q1-2024-adj-eps-123-misses-098-estimate-sales-131900m-beat-128411m-estimate

iRhythm Technologies (NASDAQ:IRTC) reported quarterly losses of $(1.23) per share which missed the analyst consensus estimate o...

 irhythm-prices-upsized-offering-of-575m-of-150-convertible-senior-notes-due-2029

iRhythm Technologies, Inc. ("iRhythm") (NASDAQ:IRTC), a leading digital health care company focused on creating trusted...

 tesla-spirit-airlines-new-york-community-bancorp-and-other-big-stocks-moving-lower-on-monday

U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday.

 irhythm-collaborates-with-epic-to-streamline-access-to-zio-service-and-drive-more-seamless-connectivity-between-clinicians-and-patients

iRhythm is the first medical device company to join the Epic community, using Aura to drive efficiencies through EHR integratio...

 canaccord-genuity-maintains-buy-on-irhythm-technologies-raises-price-target-to-133

Canaccord Genuity analyst William Plovanic maintains iRhythm Technologies (NASDAQ:IRTC) with a Buy and raises the price targ...

 needham-maintains-buy-on-irhythm-technologies-raises-price-target-to-137

Needham analyst David Saxon maintains iRhythm Technologies (NASDAQ:IRTC) with a Buy and raises the price target from $136 to...